Adenoid Cystic Carcinoma of Vulva: Case Report

Öz

Vulvanın adenoid kistik karsinomu: Olgu sunumu

Öz

The adenoid cystic carcinoma (ACC) of the Bartholin’s gland (BG) is one of the most 

uncommon variant of vulvar malignancies representing only 10–15% of cases. Risk 

factors to the development of ACCBG are still unclear. The symptoms are usually 

non-specific . 

In the present study, we present a 61-year-old woman with a vulvar mass evolving 

since 4 years, without pruritus or pains, without other signs. She initially benefited of 

an excisional biopsy of the mass returning in favour of a nodular hidradenoma. The 

evolution after 1 year was marked by the recurrence of the mass, the patient had an 

ablation of the masse then a total vulvectomy and bilateral lymph node dissection 

because pathology showed ACC of Bartholin’s gland with positif surgical margins. 

She received adjuvant external beam radiation to the pelvis and on the operating 

bed. Patient’s evolution was marked by complete remission maintained after 4years 

follow-up.

Conclusion : Adenoid cystic carcinoma of vulva is an extremely rare, slowly 

progressing neoplasm mostly involving the Bartholin’s gland. The usual treatment 

includes wide excision and adjuvant radiotherapy (if required). There may be late 

local and distant recurrence.

Anahtar Kelimeler

• adenoid cystic carcinoma,bartholin's gland,surgery,radiotherapy,chemotherapy,surhical margins

Kaynakça

1. REFERENCES:[1] Laurie SA, Ho AL, Fury MG, et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 2011;12:815–24.[2] Chaudhry AP, Leifer C, Cutler LS, et al. Histogenesis of adenoid cystic carcinoma of the salivary glands. Light and electronmicroscopic study. Cancer 1986;58:72–82.[3] Canyilmaz E, Uslu GH, Memıs¸ Y, et al. Adenoid cystic carcinoma of the breast: a case report and literature review. Oncol Lett 2014;7:1599–601.[4] Eriko T, Tadahiro S, Miura J, et al. Chemoradiotherapy with irinotecan (CPT-11) for adenoid cystic carcinoma of Bartholin’sgland: a case report and review of the literature. Gynecol Oncol Rep. 2013;4:16–9.[5] Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary origin.Aclinicopathologic study of242 cases.AmJ Surg1974;128:512–20.[6] Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007Surveillance, Epidemiology, and End Results data. Cancer 2012;118: 4444–51.[7] Finan MA, Barre G. Bartholin’s gland carcinoma, malignant melanoma and other rare tumours of the vulva. Best Pract Res Clin Obstet Gynaecol 2003;17:609e33.[8] Chamlian DL, Taylor HB. Primary carcinoma of Bartholin’s gland. A report of 24 patients. Obstet Gynecol 1972;39:489e94.[9] Copeland LJ, Sneige N, Gershenson DM, Saul PB, Stringer CA, Seski JC. Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol1986;67:115e20.[10] Bernstein SG, Voet RL, Lifshitz S, Buchsbaum HJ. Adenoid cystic carcinoma of Bartholin’s gland. Case report and review of the literature. Am J Obstet Gynecol 1983;147:385e90.[11] Lelle RJ, Davis KP, Roberts JA. Adenoid cystic carcinoma of the Bartholin’s gland: The University of Michigan experience. Int J Gynecol Cancer 1994;4:145e9.[12] Yang SY, Lee JW, Kim WS, Jung KL, Lee SJ, Lee JH, et al. Adenoid cystic carcinoma of the Bartholin’s gland: report of two cases and review of the literature. Gynecol Oncol 2006;100:422e5.[13]. Rosenberg P, Simonsen E, Risberg B. Adenoid cystic carcinoma of Bartholin’s gland: a report of five new cases treated with surgery and radiotherapy. Gynecol Oncol. 1989;34:145–7.[14]. Copeland LJ, Sneige N, Gershenson DM, Saul PB, Stringer CA, Seski JC. Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol. 1986;67(1):115–20.[15]. Alsan CI, Vinh-Hung V, Eren F, Abacioğlu U. Adenoid cystic carcinoma of theBartholin’s gland: case report and systematic review of the literature. Eur JGynaecol Oncol. 2011;32(5):567–72.